AbbVie (ABBV) Cash from Operations (2012 - 2026)

AbbVie has disclosed Cash from Operations across 15 years of filings, most recently posting 3829000000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 134.19% year-over-year to 3829000000.0; the TTM figure through Mar 2026 stood at 21224000000.0 (up 29.41% YoY), while the FY2025 annual figure was 19030000000.0, up 1.19% from the prior year.
• Cash from Operations declined to 3829000000.0 in Q1 2026, from 5218000000.0 in the prior quarter.
• Over the last five years, Cash from Operations for ABBV reached as high as 7602000000.0 in Q3 2022 and fell as low as 1635000000.0 in Q1 2025.
• The 5-year median for Cash from Operations is 5153000000.0 (2025), against an average of 5261588235.29.
• Annual changes were most pronounced in 2024 — Cash from Operations tumbled 64.06% — and 2026, when it soared 134.19%.
• A 5-year view of Cash from Operations shows it stood at 7428000000.0 in 2022, then slumped by 36.01% to 4753000000.0 in 2023, then surged by 48.29% to 7048000000.0 in 2024, then fell by 25.96% to 5218000000.0 in 2025, then declined by 26.62% to 3829000000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 3829000000.0, 5218000000.0, and 7024000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.